news Inhibiting cadherin 11 significantly increases survival of mice with pancreatic cancer 9 December 2020 | By Hannah Balfour (Drug Target Review) Mice treated with a small molecule inhibitor of cadherin 11 (CDH11) had reduced pancreatic cancer growth and increased survival time.
news Study identifies potential therapeutic targets for most lethal pancreatic cancer 15 September 2020 | By Hannah Balfour (Drug Target Review) The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
news Gut microbiome directs immune system to fight cancer 4 April 2019 | By Drug Target Review The advent of immune checkpoint inhibitors is a major breakthrough in cancer immunotherapy...
news FDG PET shows tumour DNA levels in blood are linked to NSCLC 8 November 2017 | By Dr Zara Kassam (Drug Target Review) Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer...
news TSRI scientists use ligands to turbocharge drug discovery 23 January 2017 | By Niamh Marriott (Drug Target Review) Ligands are useful tools for studying how proteins work in cells and could lead to the development of new drugs.